Dosing with Enbrel® can be individualised based on the needs of each patient1
Patients treated with Enbrel should be given the Patient Card.
The recommended dose of Enbrel for paediatric patients (aged 6 years and above) with plaque PsO is weight-based:1
Treatment should be discontinued in paediatric PsO patients who show no response after 12 weeks. If re-treatment with Enbrel is indicated, the above guidance on dosage and treatment duration should be followed1
Pfizer has resources available to support you and your Enbrel patients
Legal Category: S1A
Further information is available upon request
The information contained on this site is reserved exclusively for healthcare professionals resident in the Republic of Ireland.
I confirm that I am a healthcare professional resident in the Republic of Ireland.*
If you select 'No', you will be redirected to Pfizer.ie, where you will be able to access information on Pfizer Healthcare Ireland.
PP-UNP-IRL-0176. January 2023